---
title: "The Power of Randomization "
---

It is crucial to recognize that randomization isn't magic. When a sufficiently
large population is randomly divided into two groups, these groups will be
remarkably similar in both observable and unobservable characteristics. By
assigning one group to a treatment and leaving the other as a control, any
difference in the outcome of interest can be confidently attributed to the
treatment. As we discussed in Chapter 1, causal inference can be conceptualized
as a missing data problem. In a randomized experiment, this problem is
simplified because we effectively have data missing at random, allowing us to
make unbiased estimates of causal effects.

### The Importance of SUTVA: The Cornerstone of Valid Inference 

However, it's crucial to remember that the success of both RCTs and A/B tests
hinges on a fundamental assumption: the Stable Unit Treatment Value Assumption
(SUTVA). SUTVA has two main components:

  - **No Interference:** The treatment applied to one unit (individual, user,
    etc.) should not affect the outcome of another unit.

  - **Consistency:** The potential outcome of a unit under a treatment should be
    the same regardless of how other units are assigned.

In simpler terms, SUTVA ensures that the effect of the treatment is solely due
to the treatment itself and not influenced by other factors or interactions
between units.

#### SUTVA Violations: When the Ideal Meets Reality 

While SUTVA is often assumed, it can be easily violated:

  - **Network Effects:** Consider an A/B test of a new social media feature. If
    users in the treatment group interact with users in the control group, the
    feature's impact might spread beyond the intended group, violating SUTVA.

  - **Market Competition:** Testing a new pricing strategy might trigger
    competitor reactions, indirectly affecting the outcome even for users not
    exposed to the new price.

  - **Spillover Effects:** In advertising, a targeted campaign for one product
    might unintentionally increase awareness or sales of related products.

#### Mitigating SUTVA Violations 

Sometimes, the solution to a SUTVA violation can be as simple as **changing the
unit of randomization.** For instance, running geo-experiments in geographically
isolated markets can minimize interaction between groups. In other cases,
solutions require more intricate study designs. When complete elimination isn't
feasible, it's crucial to **acknowledge and mitigate** the potential impact of
SUTVA violations on your conclusions.

::: {.callout-note title="Key Takeaway:"}
Understanding and addressing SUTVA is essential for designing experiments and
drawing valid conclusions. By carefully considering the potential for
interference and inconsistency, researchers and practitioners can design more
robust experiments and make more informed decisions based on their findings.
:::

::: {.callout-tip}
## Learn more
  - @chernozhukov2024applied Applied causal inference powered by ML and AI.
:::

### Baseline equivalence  and Sample Size Considerations

Baseline equivalence is a critical, particularly in experiments with a small
sample size or observational studies. It refers to the similarity of groups
(e.g., treatment and control groups) on key characteristics before an
intervention or treatment is introduced. Without baseline equivalence, observed
differences in outcomes could be due to pre-existing differences between the
groups, rather than the intervention itself. For instance, if a company is
testing a new algorithm to increase user engagement on their platform, and the
treatment group (those exposed to the new algorithm) already had higher baseline
engagement levels than the control group, any observed increase in engagement in
the treatment group might be due to their pre-existing behavior, not necessarily
the new algorithm.

#### The Risk of Small Sample Sizes

It's important to emphasize that achieving baseline equivalence is particularly
challenging with small sample sizes. As @wainer2007most points out in "The Most
Dangerous Equation," small samples are inherently more variable, making it more
likely that random chance will lead to imbalances between groups, even with
randomization. This can lead to the erroneous conclusion that an effect exists
when it truly doesn't (a Type I error), or vice-versa (a Type II error).
Therefore, in smaller experiments, careful attention to baseline equivalence and
potential statistical adjustments are paramount.

#### Establishing Baseline Equivalence

In RCTs, random assignment of participants to treatment and control groups is
should warranty baseline equivalence as long as the group is large enough.
However, even in large RCTs, factors like attrition (loss of participants) or
reassignment (participants switching groups) can compromise baseline
equivalence. In such cases, you will need employ statistical techniques to
adjust for any remaining differences between the groups.

In non-randomized studies (quasi-experimental designs), establishing baseline
equivalence is more challenging. You can use techniques to match treated units
to units that are untreated but look similar in observable characteristics.
However, it's important to note that these methods cannot guarantee equivalence
on unobserved characteristics, which could still bias the results.

#### Assessing Baseline Equivalence

To assess baseline equivalence, we can examine pre-intervention outcomes and
other relevant observable characteristics. A common approach is to calculate the
effect size, defined as the difference in means between the treatment and
control groups divided by the pooled standard deviation.

It is generally accepted that if the absolute value of the effect size is
greater than 0.25, baseline equivalence is not established, and statistical
adjustments are unlikely to adequately correct for the differences. When the
absolute value of the effect size falls between 0.05 and 0.25, statistical
adjustments are necessary to achieve baseline equivalence. An absolute value
less than 0.05 indicates strong evidence of baseline equivalence.

::: {.callout-tip}
## Learn more
  - @wwc_baseline What Works Clearinghouse Baseline Equivalence Standard.
:::

### An example using code

Let's delve into the concept of baseline equivalence with synthetic data.
Suppose we're analyzing a population of 10,000 individuals, each characterized
by two traits: x1, observable to us, and e1, which remains hidden. Given the
large sample size, if we randomly split this population into two groups, we can
expect these groups to be statistically similar. Let's see this in action:

```{r fake_data}
set.seed(941998)
N <- 10000  # Our synthetic dataset comprises 10,000 observations

fake_data <- tibble::tibble(
  x1 = rnorm(n = N, mean = 5000, sd = 500),
  e1  = rnorm(n = N, mean = 7000, sd = 900),
  t = sample(
    x = c(TRUE, FALSE),
    size = N,
    replace = TRUE,
    prob = c(0.5, 0.5)
  )
)

```

We can examine the mean values for the two groups:


```{r mean}
means <- fake_data |>
  dplyr::group_by(t) |>
  dplyr::summarise(mean_x1 = mean(x1),
                   mean_e1 = mean(e1))

# Calculate the differences between means for x1 and e1
mean_diff_x1 <- means$mean_x1[2] - means$mean_x1[1]
mean_diff_e1 <- means$mean_e1[2] - means$mean_e1[1]

cat("Difference in mean_x1 between t = TRUE and t = FALSE:", mean_diff_x1, "\n")
cat("Difference in mean_e1 between t = TRUE and t = FALSE:", mean_diff_e1, "\n")
```

However, simply observing the difference in means might not provide a clear picture of the magnitude. Let's assess the effect size:

```{r}
pooled_sd_x1 <- sd(fake_data$x1)
pooled_sd_e1 <- sd(fake_data$e1)

abs_effect_size_x1 <- abs(mean_diff_x1 / pooled_sd_x1)
abs_effect_size_e1 <- abs(mean_diff_e1 / pooled_sd_e1)

cat("Absolute value of the effect size for x1 is:", abs_effect_size_x1, "\n")
cat("Absolute value of the effect size for e1 is:", abs_effect_size_e1, "\n")
```

Here, we can observe that despite randomization, the two groups are statistically identical. However, what if our sample size is much smaller?

```{r small_fake_data}
set.seed(941998)
N <- 10  # Our synthetic dataset comprises 10 observations

fake_data2 <- tibble::tibble(
  x1 = rnorm(n = N, mean = 5000, sd = 500),
  e1  = rnorm(n = N, mean = 7000, sd = 900),
  t = sample(
    x = c(TRUE, FALSE),
    size = N,
    replace = TRUE,
    prob = c(0.5, 0.5)
  )
)

means <- fake_data2 |>
  dplyr::group_by(t) |>
  dplyr::summarise(mean_x1 = mean(x1),
                   mean_e1 = mean(e1))

# Calculate the differences between means for x1 and e1
mean_diff_x1 <- means$mean_x1[2] - means$mean_x1[1]
mean_diff_e1 <- means$mean_e1[2] - means$mean_e1[1]

pooled_sd_x1 <- sd(fake_data2$x1)
pooled_sd_e1 <- sd(fake_data2$e1)

abs_effect_size_x1 <- abs(mean_diff_x1 / pooled_sd_x1)
abs_effect_size_e1 <- abs(mean_diff_e1 / pooled_sd_e1)

cat("Absolute value of the effect size for x1 is:", abs_effect_size_x1, "\n")
cat("Absolute value of the effect size for e1 is:", abs_effect_size_e1, "\n")
```

With a smaller sample size, we see significant differences between the two
groups, even with randomization. The disparity in the unobservable
characteristic (e1) is particularly large. If we were to compare outcomes for
these groups, which are influenced by this unobservable characteristic, we might
mistakenly attribute any differences to the intervention being studied.

### The {im} package

The {im} package provides a convenient way to check baseline equivalence using
the `im::checkBaseline` function and visualize the results with
`im::balancePlot`.

```{r baseline}
balance <-
  im::checkBaseline(data = fake_data,
                    variables = c("x1", "e1"),
                    treatment = "t")
balance

im::balancePlot(data = balance)
```

You can also randomize data using `im::randomize`. This function iteratively
re-randomizes until achieving a specified level of baseline equivalence or
reaching a maximum number of attempts.

```{r im::randomizer}
my_data <- tibble::tibble(
  x1 = rnorm(10000), 
  x2 = rnorm(10000)
)

# Randomize
randomized <- im::randomizer$new(
  data = my_data, 
  seed = 12345, 
  max_attempts = 1000,
  variables = c("x1", "x2"), 
  standard = "Not Concerned"
)

# Get Randomized Data
randomized$data

# Get Balance Summary
randomized$balance_summary

# Generate Balance Plot
randomized$balance_plot

```


## Stratified Randomization

While random assignment is effective, unforeseen factors can sometimes lead to
imbalanced groups. Stratified randomization addresses this by dividing users
into subgroups (strata) based on relevant characteristics that are believed to
influence the outcome metric. Randomization is then performed within each
stratum, ensuring that both treatment and control groups have a similar
proportion of users from each subgroup.

This approach strengthens experiments by creating balanced groups. For instance,
if user location is expected to affect the outcome metric, users can be
stratified by location (e.g., urban vs. rural), followed by randomization within
each location. This ensures a similar distribution of user attributes across
treatment and control groups, controlling for confounding factorsâ€”user traits
that impact both exposure to the new feature and the desired outcome. With
balanced groups, any observed differences in the outcome metric are more likely
due to the new feature itself, leading to more precise and reliable results.

### Examples 

  - **Targeting Mobile App Engagement:** In an RCT to evaluate a new in-app
    notification, user location (urban vs. rural) is suspected to influence user
    response. Stratification by location, followed by randomization within each
    stratum, can control for this factor.

  - **Personalizing a Recommendation Engine:** When A/B testing a revamped
    recommendation engine, past purchase history is hypothesized to influence
    user response. Stratification by purchase history categories (e.g., frequent
    buyers of clothing vs. electronics), followed by randomization within each
    category, can account for this.

### Advantages:

  - **Reduced bias:** Stratification helps isolate the true effect of the new
    feature by controlling for the influence of confounding factors. This leads
    to more reliable conclusions about the feature's impact on user behavior.

  - **Improved decision-making:** By pinpointing the feature's effect on
    specific user groups (e.g., urban vs. rural in the notification example),
    stratified randomization can inform decisions about targeted rollouts or
    further iterations based on subgroup performance.

### Disadvantages:

  - **Increased complexity:** Designing and implementing stratified randomization
requires careful planning to choose the right stratification factors and ensure
enough users within each stratum for valid analysis.

  - **Need for larger sample sizes:** Maintaining balance across strata might
necessitate a larger overall sample size compared to simple random assignment.

### Example with code

Let's illustrate the concept of stratified randomization with a practical
example. Consider a scenario where we have data on 10,000 individuals, each
described by two continuous variables (x1 and x2) and two categorical variables
(x3 and x4). We suspect that variable x3 might be a confounding factor
influencing the outcome of our experiment.

```{r stratified}
my_data <- tibble::tibble(
  x1 = rnorm(10000), 
  x2 = rnorm(10000),
  x3 = rep(c("A", "B"), 5000),
  x4 = rep(c("C", "D"), 5000)
)

# Create a Randomizer Object
randomized <- im::randomizer$new(
  data = my_data, 
  seed = 12345, 
  max_attempts = 1000,
  variables = c("x1", "x2"), 
  standard = "Not Concerned",
  group_by = "x3"
)

# Generate Balance Plot
randomized$balance_plot
```


In this code, we're using the im::randomizer function to create an object that
will help us perform stratified randomization. We specify x3 as the variable to
stratify by, ensuring that the treatment and control groups have a balanced
distribution of individuals from both categories of x3.

By incorporating stratified randomization into our experimental design, we can
effectively control for the influence of variable x3, enhancing the internal
validity of our study and allowing for more precise estimates of causal effects.

In conclusion, stratified randomization offers a powerful way to enhance the
rigor and precision of experiments, particularly when dealing with potential
confounding factors. While it may introduce some additional complexity and
potentially require larger sample sizes, the benefits in terms of internal
validity and the ability to draw more nuanced conclusions often outweigh these
drawbacks. The thoughtful use of stratified randomization can be a valuable
asset in the causal inference toolkit.